Skip to main navigation Skip to main content Skip to page footer

Strengthening Clinical Research: Standard Contractual Clauses and Further Steps Toward a Competitive Location for Clinical Trials

Contract Negotiations for Clinical Trials: How Do the Ordinance and Other Measures Help? was the title and central question of a symposium held in Berlin on 10 March. It brought together representatives from the Federal Ministry of Health, academic research and the research-based pharmaceutical industry. The symposium was hosted by the association platform comprising German University Medicine (DHM), the KKS Network, the German Association of Research-Based Pharmaceutical Companies (vfa), the Federal Association of Medical Contract Research Organisations (BVMA), the Federal Association of the Pharmaceutical Industry (BPI) and the Federal Association of Medical Technology (BVMed).

The symposium focused on how the new standard contractual clauses for contracts on participation in clinical trials work in practice, and which further steps are needed to strengthen Germany sustainably as a location for research and development.

 

KKSN KKSN